Tag: off-label litigation

CHC_FDA-Regulatory Images1

OPDP’s Abrams: Enforcement Still a Priority, Despite Decrease in Letters

CHC_firstamendment3

Courts’ Support for “Truthful and Non-misleading” Speech Has Not Yet Resulted in FDA Policy Change

Jury Says “Not Guilty” to Off-label Charges in Medical Device Case

Which Standard of Truth Will Be Used To Evaluate Non-misleading Ad Claims?

Pacira Files Complaint Calling FDA Marketing Restrictions Unconstitutional

Amarin Federal Court Decision: FDA Off-Label Marketing Rules Violate the First Amendment By John Kamp

FDA Plans for Off-label Communication Draft Guidance, Meeting

In Amicus Brief, PhRMA Says Off-label Case “Raises Serious First Amendment Concerns”

Caronia Decision One Year Later: Off-label Change May Be Slow, But It’s Brewing